Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Bevacizumab (drug) published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-11 of 11
» View all items
    Apr 19, 2013 |Story| Los Angeles Times

  1. Strategies for cutting the cost of prescription drugs

    When Maggie Heim had a recurrence of ovarian cancer about a year after her initial treatment, her oncologist suggested that she take what he believed could be a lifesaving drug. There was just one problem: Her insurer wouldn't pay for it.
    When Maggie Heim had a recurrence of ovarian cancer about a year after her initial treatment, her oncologist suggested that she take what he believed could be a lifesaving drug. There was just one problem: Her insurer wouldn't pay for it. The 59-year-...

    Tags: Oncology, Trials, Multiple Sclerosis, National Institutes of Health, Prescription Drugs

    2. Apr 23, 2013 |Story| Los Angeles Times

  2. Cancer drug may double as fat-busting treatment for obesity

    Way back in 2002, Dr. Judah Folkman hit upon a tantalizing weight-loss strategy for obese mice. When given daily injections of a drug designed to fight cancer, their fat melted away. The higer the dose they got, the more fat they lost. Some of the obese mice shed so much weight that they wound up at &ldquo;near normal body weights,&rdquo; Folkman and his colleagues reported <a href="http://www.pnas.org/content/99/16/10730.full.pdf">in this article</a> in Proceedings of the National Academy of Sciences.
    Way back in 2002, Dr. Judah Folkman hit upon a tantalizing weight-loss strategy for obese mice. When given daily injections of a drug designed to fight cancer, their fat melted away. The higer the dose they got, the more fat they lost. Some of the obese...

    Tags: Science and Technology, University of Mississippi, Obesity, Medical Research, Weight

    3. Mar 29, 2013 |Story| Los Angeles Times

  3. Remove Medicare's straitjacket

    Now that the budget "sequester" is in effect, Congress is shifting its attention to entitlement reform. There's simply no way to achieve long-term reductions in federal spending without touching the big health programs, particularly Medicare. Although raising the age of Medicare eligibility from 65 to 67 appears off the table, at least for now, the budget plan that Rep. Paul D. Ryan (R-Wis.) is proposing would shift a greater share of the program's growing costs to beneficiaries in the years to come.
    Now that the budget "sequester" is in effect, Congress is shifting its attention to entitlement reform. There's simply no way to achieve long-term reductions in federal spending without touching the big health programs, particularly Medicare. Although...

    Tags: New Products, U.S. Congress, Genentech Inc., Science and Technology, Private Health Care

    4. Oct 27, 2012 |Story| Los Angeles Times

  4. For the record

    Medical study results: In the Oct. 24 Section A, an article about medical studies said that follow-up studies of the drug Avastin showed that it did not help breast cancer patients live longer with their disease without getting worse. Those studies did...

    Tags: Sports, Football, Breast Cancer

    5. Jun 20, 2012 |Story| Los Angeles Times

  5. The New War on Cancer

    &nbsp;It used to be that the cancer doctor&rsquo;s toolbox contained three essential tools <span>&mdash;</span> a scalpel to cut out the disease, chemo to poison it and radiation to zap it.
     It used to be that the cancer doctor’s toolbox contained three essential tools — a scalpel to cut out the disease, chemo to poison it and radiation to zap it. But today that toolbox is bulging with new and better weapons. “We’re...

    Tags: Diseases and Illnesses, Oncology, Lymphatic System, Healthcare Provider, Cancer

    6. Jan 30, 2012 |Story| Los Angeles Times

  6. New Avastin tests add to confusion over use in breast cancer

    In November, following an emotional public hearing some months earlier, the Food and Drug Administration withdrew approval for the cancer drug Avastin for patients with metastatic breast cancer &mdash; the late-stage, incurable form of the disease. The reason: emerging evidence that the drug does not prolong life and also that it's been linked to serious side effects.
    In November, following an emotional public hearing some months earlier, the Food and Drug Administration withdrew approval for the cancer drug Avastin for patients with metastatic breast cancer — the late-stage, incurable form of the disease. The...

    Tags: Diseases and Illnesses, Medical Specialization, Cancer, Colon Cancer, Genentech Inc.

    7. Nov 18, 2011 | Los Angeles Times

  7. Caughlin fire: 20 structures destroyed, thousands evacuated in Reno

    Nation Now
    Caughlin Fire: The out-of-control Caughlin Fire in Reno has destroyed 20 homes and forced 9,500 people to evacuate....
    8. Nov 18, 2011 | Los Angeles Times

  8. New drilling could bring highway money, GOP leaders say

    Nation Now
    Congressional Republican leaders are drafting legislation that would steer money from new offshore energy production into highway construction....
    9. Nov 18, 2011 | Los Angeles Times

  9. Killer Paul Rhoades executed by lethal injection in Idaho

    Nation Now
    Convicted killer Paul Ezra Rhoades executed in Idaho...
    10. Jun 28, 2011 | Los Angeles Times

  10. Avastin: There's the truth and then there's the politics behind the cancer drug [The conversation]

    Opinion L.A.
    Avastin: The FDA goes up against drug manufacturer Genentech with regards to the late-stage cancer drug....
    11. Jul 23, 2010 |Resource Link| Los Angeles Times

  11. American Obesity

    Tags: Steve Jobs, Cancer, Physical Conditions, Health, Billy Graham

Advertisement
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Bevacizumab (drug) Photos
A sign is displayed in front of the Genentech headquart...
(December 13, 2012)
A sign is displayed in front of the Genentech headquarters July 14, 2008 in South San Francisco, California. This company relied on the popularity of its cancer drug Avastin to boost profits.
FDA withdraws approval of Avastin for breast cancer pat...
(November 18, 2011)
the cancer drug avastin
, saying studies have failed to prove the drug's effect...
(July 1, 2011)
FDA panel rejects Avastin for breast cancer, but Medicare will still pay for it -- and Provenge
 » All 4 Bevacizumab (drug) photos